Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6.99M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
2.12M
-
Shares change
-
+31.7K
-
Total reported value, excl. options
-
$5.65M
-
Value change
-
+$83.5K
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$2.67
Significant Holders of Minerva Neurosciences, Inc. - Common Stock (NERV) as of Q3 2024
21 filings reported holding NERV - Minerva Neurosciences, Inc. - Common Stock as of Q3 2024.
Minerva Neurosciences, Inc. - Common Stock (NERV) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.12M shares
of 6.99M outstanding shares and own 30.28% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (1.35M shares), VANGUARD GROUP INC (252K shares), RENAISSANCE TECHNOLOGIES LLC (157K shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (107K shares), BlackRock, Inc. (72.7K shares), GEODE CAPITAL MANAGEMENT, LLC (56.5K shares), NORTHERN TRUST CORP (23K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (20.2K shares), ACADIAN ASSET MANAGEMENT LLC (17.4K shares), and CITADEL ADVISORS LLC (17.2K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.